FDA approves Moderna's mRNA-based flu vaccine for older people
Most outlets led with the approval of Moderna’s new mRNA-based flu vaccine for older people, highlighting its use of the same technology that played a key role in the development of the COVID-19 vaccines. Arab News Pakistan added context about the FDA’s approval and the significance of the vaccine, while The News International framed the headline as a public information piece titled “What you need to know,” though the excerpt does not specify further details of this framing.
How 2 outlets covered this — an automatically generated summary. Each outlet's own headline and excerpt are below.
Same story from 2 outlets
Each outlet's own headline, most recent first — read any at its source.
-
FDA approves Moderna's mRNA-based vaccine: What you need to know
FDA approves Moderna’s mRNA-based vaccine: What you need to knowThe Food and Drug Administration has reportedly approved a new kind of flu vaccine for older people: a pioneering mRNA formulation that was key to ending the acute phase of the COVID-19 pandemic. The shot primarily named...
-
New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine
WASHINGTON: The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, manufacturer Moderna said. The shot, named mFlusiva, is intended for adults age 50 or older. Other brands of flu shots already have begun arriving in pharmacies ahead of fall vaccination season, and Moder...
2 articles from 2 outlets, 6 Aug–6 Aug 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. What does % identical mean?